The Top Analysis for Gilead Sciences, Inc. (GILD)


The top analysis was written by Noah Brody titled Which is the Better Buy? Gilead Sciences vs Bristol-Myers Squibb

Is Gilead Sciences, Inc. (GILD) a buy?

Based on 3 suggestions, Gilead Sciences, Inc.(GILD) is recommended as a HOLD at $72.21.

Are These Ratings Good?

Based on 3 ratings, the average Return is -6.74%.
The community has not been successfully rating this stock.

Forecast for Gilead Sciences, Inc. (GILD)

Based on the most recent price of $67.65,
the two year forecast for GILD is $68.66.
The four year forecast is $69.68
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.